| Product NDC: | 0378-4092 |
| Proprietary Name: | Ropinirole Hydrochloride |
| Non Proprietary Name: | ropinirole hydrochloride |
| Active Ingredient(s): | 6 mg/1 & nbsp; ropinirole hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0378-4092 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200462 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121016 |
| Package NDC: | 0378-4092-77 |
| Package Description: | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-4092-77) |
| NDC Code | 0378-4092-77 |
| Proprietary Name | Ropinirole Hydrochloride |
| Package Description | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-4092-77) |
| Product NDC | 0378-4092 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ropinirole hydrochloride |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20121016 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | ROPINIROLE HYDROCHLORIDE |
| Strength Number | 6 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |